Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 2/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.38 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.38 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.35 |
| ▸ | FASN | P49327 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7906013 | 0.79 | MAOB (0.49) | MAOBF2PRSS1DDB1CRBN | |
| SCHEMBL7899581 | 0.79 | MAOB (0.49) | MAOBF2PRSS1DDB1CRBN | |
| SCHEMBL3685687 | 0.79 | MAOB (0.49) | MAOBF2PRSS1DDB1CRBN | |
| SCHEMBL21850372 | 0.76 | GAA (0.43) | MAOBF2PRSS1DDB1CRBN | |
| SCHEMBL14159745 | 0.76 | GAA (0.43) | MAOBF2PRSS1DDB1CRBN | |
| SCHEMBL8772735 | 0.75 | GBA1 (0.46) | MAOB | |
| SCHEMBL14159890 | 0.70 | MAOB (0.39) | MAOBF2PRSS1DDB1CRBN | |
| SCHEMBL14159746 | 0.70 | MAOB (0.39) | MAOBF2PRSS1DDB1CRBN | |
| SCHEMBL14159784 | 0.70 | MAOB (0.39) | MAOBF2PRSS1DDB1CRBN | |
| SCHEMBL14159750 | 0.70 | MAOB (0.39) | MAOBF2PRSS1DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180279615-A1 | PYRIDINE DERIVATIVES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2018-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180279615-A1 | PYRIDINE DERIVATIVES FOR COMBATING PHYTOPATHOGENIC FUNGI | G6PD, NQO1, PNPO | MAOB 206/4885F2 1904/4885PRSS1 2415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.